Top Sell
| Security | Buy | Sell | Buy (1M) ▲ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Sage Therapeutics Inc. | 5 | 2 | 0 | 0 | €7.11 | €21.44 | 201.354% |
| BioLine RX Ltd ADR | 0 | 1 | 0 | 0 | €0.62 | - | - |
| Biofrontera AG | 0 | 1 | 0 | 0 | €0.33 | - | - |
| Synthetic Biologics Inc. | 0 | 1 | 0 | 0 | €0.12 | - | - |
| Medigene AG | 1 | 1 | 0 | 0 | €1.06 | - | - |
| Amarin Corp. ADR | 2 | 1 | 0 | 0 | €0.54 | - | - |
| Viking Therapeutics Inc | 5 | 1 | 0 | 1 | €55.44 | - | - |
| Protalix Biotherapeutics Inc. | 1 | 1 | 0 | 0 | €0.82 | €2.00 | 144.320% |
| Natural Alternat. | 19 | 1 | 0 | 0 | €4.72 | - | - |
| Bristol-Myers Squibb | 7 | 3 | 0 | 1 | €44.30 | €67.64 | 52.701% |
| Palisade Bio Inc. | 3 | 1 | 0 | 0 | €0.34 | €21.06 | 6072.333% |
| Xenon Pharmaceuticals Inc. | 1 | 1 | 0 | 0 | €36.20 | €50.00 | 38.122% |
| Uniqure B.V. | 1 | 2 | 0 | 0 | €5.46 | €11.00 | 101.539% |
| Rocket Pharmaceuticals Inc | 2 | 1 | 0 | 0 | ? | €32.00 | 92.019% |
| Enlivex Therapeutics Ltd. | 0 | 1 | 0 | 0 | €1.07 | - | - |
| Cytomx Therapeutics Inc | 2 | 1 | 0 | 0 | €1.04 | €50.00 | 4712.320% |
| Moleculin Biotech Inc | 3 | 25 | 0 | 2 | €0.41 | €18.42 | 4393.659% |
| Coherus Bioscien. | 1 | 2 | 1 | 0 | €1.23 | - | - |
| Aspira Womens Health Inc. | 1 | 1 | 1 | 0 | €0.85 | €4.99 | 487.341% |
| Agenus Inc. | 4 | 2 | 1 | 0 | €0.41 | €37.02 | 8846.834% |
| Fate Therapeutics Inc. | 4 | 3 | 1 | 0 | €3.22 | €7.31 | 127.384% |
| Gritstone Oncology Inc | 6 | 1 | 2 | 0 | €0.42 | €3.68 | 785.501% |
| Syros Pharmaceuticals Inc. | 9 | 1 | 3 | 0 | €1.47 | €12.01 | 716.701% |
| Karyopharm Therapeutics Inc. | 8 | 1 | 3 | 0 | €0.71 | €5.49 | 673.732% |
| Bluebird Bio Inc. | 7 | 6 | 3 | 0 | €0.56 | €5.47 | 874.093% |